Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of high-dose vitamin B6 injection in clinical use
ChiCTR2300072496Phase 4Completed
- Sponsor
- Changzhou Wujin People's Hospital
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of pyridoxine in vitamin B6 deficiency (2 arms), sponsored by Changzhou Wujin People's Hospital. Primary endpoints: Glutamyl aminotransferase, Alanine transaminase and 3 more. Started Aug 2022; status: completed.
02
Drugs
pyridoxine
03
Conditions
vitamin B6 deficiency
Beyond the preview
Go deeper on ChiCTR2300072496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072496.